1.

Which pharma company has completed trials for its intranasal Covid vaccine candidate?

Answer» Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.


Discussion

No Comment Found